ACM
GCVRZ

Argentus Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Argentus Capital Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-100
Closed -$14 – 727
2015
Q3 		$0 Buy
+100
New +$34 ﹤0.01% 701

Other funds holding GCVRZ

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Argentus Capital Management's GCVRZ Position: Q4 2015 in Review

Argentus Capital Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2015, closing a stake of 100 shares — an estimated $14 sold.

Argentus Capital Management first reported a position in GCVRZ in Q3 2015 and held it in 1 quarter. The position peaked at $0 in Q3 2015. 114 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2015.

  • Argentus Capital Management reported no remaining Sanofi Contingent Value Rights position as of Q4 2015 after selling out during the quarter.
  • Argentus Capital Management sold 100 Sanofi Contingent Value Rights shares in Q4 2015, an estimated $14.
  • Argentus Capital Management first reported a position in Sanofi Contingent Value Rights in Q3 2015 and held it in 1 quarter.
  • Argentus Capital Management's Sanofi Contingent Value Rights position peaked at $0 in Q3 2015.
  • 114 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2015.

Based on Argentus Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.